A verification study of the blood glucose response: a randomized, placebo-controlled, double-blind, crossover comparison trial - A verification study of the blood glucose response

ORTHOMEDICO Inc.0 sites10 target enrollmentSeptember 28, 2023

Overview

No summary available.

Registry

who.int

Start Date

September 28, 2023

End Date

October 10, 2023

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

•1\. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2\. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3\. Subjects currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4\. Subjects who use or take "Foods for Specified Health Uses", or "Foods with Functional Claims" in daily 5\. Subjects who are currently taking medications (including herbal medicines) and supplements 6\. Subjects who are allergic to medicines and/or the test food related products 7\. Subjects who are pregnant, lactating, or planning to become pregnant during this trial 8\. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 9\. Subjects who are judged as ineligible to participate in this study by the physician